Academia
The use of structured data and automation can accelerate antibody engineering as much as 50%, Prem Mohanty, product marketing manager and life sciences product specialist for Benchling, told BioSpace.
In a groundbreaking new study, scientists at Harvard University have identified one enzyme that seems to dictate the limits of our physical performance.
According to new data from the EAST-AFNET 4 trial that was released on Aug. 29, patients with atrial fibrillation appear to benefit from early rhythm control therapy.
Research published in Lancet Oncology August 24th analyzed that risk by tumor subtype and patient demographics, looking at 1,044 patients from 60 medical centers throughout the UK.
According to data from Phase I clinical trials, a new breast cancer drug developed by researchers at the University of Illinois Chicago can potentially stop disease progression without toxicity.
A new study published in the August 26 edition of Science Advances shows that the effectiveness of a two-pronged Type 2 diabetes treatment improves when drugs are linked by a heat-sensitive tether.
According to a study published in Nature Medicine on August 17, researchers from the Stanford University School of Medicine have discovered a way to regenerate the cushion of cartilage found in joints.
AbbVie and Harvard University entered into a $30 million collaborative research alliance to develop therapies against emergent viral infections, with a focus on those caused by coronaviruses and by viruses that lead to hemorrhagic fever.
The genetic sequences of the two samples were markedly different, which strengthened the theory that the patient had been infected a second time.
A novel way to control biologic signaling allows cellular function to be modulated via cell phone, according to research presented at the American Chemical Society’s annual meeting Tuesday by researchers at the University of Maryland.
PRESS RELEASES